Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015249 · ClinicalTrials.gov registry record · Phase 1
Prepulse Inhibition of Startle in Cocaine Dependence - 7
A Phase 1 study of Substance-Related Disorders and Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT00015249 is a Phase 1 study of Substance-Related Disorders and Cocaine-Related Disorders that has completed, run by National Institute on Drug Abuse (NIDA). The trial reports 1 study location across 1 state.
The verdict
NCT00015249, a Phase 1 study of Substance-Related Disorders and Cocaine-Related Disorders, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.
Conditions Studied
Interventions
- DRUG Amantadine
Study Locations (1)
New York
- New York MDRU - New York
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-02 |
| Est. Completion | 1998-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015249
The ClinicalTrials.gov registry entry for NCT00015249 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Amantadine is the first listed.
NCT00015249 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00015249 about?
NCT00015249 is a clinical study titled "Prepulse Inhibition of Startle in Cocaine Dependence - 7". The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.
What is the current status of trial NCT00015249?
This trial is currently completed. It is a Phase 1 study. The study started on 1997-02. Estimated completion is 1998-05.
What conditions does trial NCT00015249 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Cocaine-Related Disorders.
What interventions are being tested in trial NCT00015249?
The interventions under investigation include: Amantadine (DRUG).
Who is sponsoring clinical trial NCT00015249?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015249 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
ACTIVE NOT RECRUITING · Phase 1
-
Pilot Clinical Trial of Computer-based Motivational Intervention - 1
COMPLETED · Phase 1
-
Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
COMPLETED · Phase 1
-
Cognitive Therapy for PTSD in Addiction Treatment
COMPLETED · Phase 1
-
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
COMPLETED · Phase 1
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.